It has been reported that triple-negative breast cancer (TNBC) is sensitive to the Hsp90 inhibitor PU-H71 through the inhibition of the RAS/RAF/MAPK pathway and the induction of apoptosis via the degradation of AKT and BCL-XL [101]. The gene discussed is AKT1; the disease is triple-negative breast carcinoma.